Evaluation of Hepatitis B and C Reactivation in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors. Mediterranean Journal of Hematology and Infectious Diseases, [S. l.], v. 18, n. 1, p. e2026001, 2026. DOI: 10.4084/MJHID.2026.001. Disponível em: https://www.mjhid.org/mjhid/article/view/5860. Acesso em: 29 may. 2026.